Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
Shahanas ChathothMona H IsmailHanan M AlghamdiHazem Mohamed ZakariaKhairi Ahmed HassanSaeed AlshomimiChittibabu VatteCyril CyrusHind S AlsaifAhmed MostafaHeba ShaabanAmein Al AliPublished in: Lipids in health and disease (2022)
The present study indicates that C16-ceramide plays a pivotal role in inducing insulin resistance. Overexpression of SPT1 in the obese-diabetic group and its positive correlation with C16-ceramide suggest that C16-ceramide was generated through the de novo pathway.